Expression, purification and initial characterization of human meprin β from Pichia pastoris

D Schlenzig1, M Wermann1, D Ramsbeck1

  • 1Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation (IZI-MWT), Weinbergweg 22, 06120 Halle/Saale, Germany.

Insights

Researchers expressed human meprin β (h-meprin β) in yeast, achieving high yields of a purified enzyme with activity identical to mammalian sources. This Pichia pastoris expression system facilitates further studies for drug development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • Human meprin β (h-meprin β) is a metalloendoprotease implicated in diseases like fibrosis and Alzheimer's.
  • Efficient production of active h-meprin β is crucial for therapeutic and structural studies.

Purpose of the Study:

  • To establish a Pichia pastoris expression system for producing active human meprin β.
  • To characterize the biochemical properties of yeast-expressed h-meprin β.

Main Methods:

  • Engineered h-meprin β with a modified signal sequence for secretion in Pichia pastoris.
  • Purified the enzyme using affinity and hydrophobic interaction chromatography.
  • Assessed enzymatic activity and characterized glycosylation and oligomeric state.

Main Results:

  • Isolated 58.4 mg/l of homogenous human pro-meprin β.
  • Yeast-derived h-meprin β (yh-meprin β) exhibited enzymatic activity comparable to mammalian sources.
  • yh-meprin β was secreted as an N-glycosylated dimer (148 kDa), with deglycosylation yielding a 133 kDa protein with unchanged kinetics.

Conclusions:

  • Pichia pastoris is a suitable host for high-yield expression of active human meprin β.
  • The characterized yh-meprin β demonstrates properties similar to native h-meprin β, supporting its use in inhibitor screening and drug refinement.

Related Concept Videos